Science Explorer Back to mapMap
Discussion
Researcher · Queen's University · Canada

David Monty Berman

David Monty Berman publishes mostly in Molecular Biology, Surgery and Oncology, on topics such as Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0001-5985-3698 OpenAlex
World rank
#116,492
of 7,710,434 ranked researchers
Rank in Canada
#3,741
of 183,316
Works
488
Citations
29k
Citations per work
59.5
h-index
74
i10-index 192Top 0.9% in Molecular Biology
David Monty Berman

What does David Monty Berman research?

David Monty Berman's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (4%).

Everything else: 206 works · 42.3% of their workHealth Sciences: 191 works · 39.2% of their workMedicine: 191 works · 39.2% of their workSurgery: 59 works · 12.1% of their workOncology: 56 works · 11.5% of their workPulmonary and Respiratory Medicine: 53 works · 10.8% of their workEpidemiology: 23 works · 4.8% of their workLife Sciences: 90 works · 18.5% of their workBiochemistry, Genetics and Molecular Biology: 70 works · 14.4% of their workMolecular Biology: 70 works · 14.4% of their workImmunology and Microbiology: 20 works · 4.1% of their workImmunology: 20 works · 4.1% of their workTHEIR WORKDavid MontyBerman488works
Life Sciences18%Health Sciences39%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else20642.3%
    1. Medicine19139.2%
    1. Biochemistry, Genetics and Molecular Biology7014.4%
    2. Immunology and Microbiology204.1%
  1. 1Molecular Biology14% of their works
  2. 2Surgery12% of their works
  3. 3Oncology12% of their works
  4. 4Pulmonary and Respiratory Medicine11% of their works
  5. 5Epidemiology5% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe David Monty Berman's research?

The keywords of their largest research topics: Immunotherapy, Prostate Cancer, Bladder Cancer, Urothelial Carcinoma, Androgen Receptor, Genomic Profiling, Cancer Immunotherapy and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Immunotherapy1323 topics
  2. Prostate Cancer772 topics
  3. Bladder Cancer601 topic
  4. Urothelial Carcinoma601 topic
  5. Androgen Receptor511 topic
  6. Genomic Profiling511 topic
  7. Cancer Immunotherapy432 topics
  8. Immune Checkpoint Blockade421 topic
  9. PD-1 and PD-L1421 topic
  10. Primary Urethral Carcinoma321 topic
  11. Urachal Carcinoma321 topic
  12. Radiation Therapy261 topic
  13. Screening261 topic
  14. DNA Methylation251 topic
  15. Histone Modification251 topic
  16. Dendritic Cells221 topic
  17. Immunity221 topic
  18. CAR T Cells211 topic
  19. Chimeric Antigen Receptor211 topic

Where does David Monty Berman work?

David Monty Berman's main affiliation in the publication record is Queen's University, Canada.

How many publications and citations does David Monty Berman have?

OpenAlex counts 488 works and 29,012 citations for David Monty Berman, an h-index of 74, ranking #116,492 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David Monty Berman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.